Caitlin John, LLC Acadia Pharmaceuticals Inc Transaction History
Caitlin John, LLC
- $151 Billion
- Q4 2024
A detailed history of Caitlin John, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Caitlin John, LLC holds 75 shares of ACAD stock, worth $1,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$1,114
Previous $1.32 Million
4.32%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
321Shares Held
165MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$637 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$207 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$179 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$129 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$108 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.4B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...